Bank Of Montreal Immuno Precise Antibodies Ltd. Transaction History

Bank Of Montreal

$191 Billion
Q1 2024

A detailed history of Bank Of Montreal transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Bank Of Montreal holds 53,805 shares of IPA stock, worth $54,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,805

Previous 47,521 13.22%

Holding current value

$54,343

Previous $81,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.4 - $2.41 $8,797 - $15,144	6,284 Added 13.22%	53,805 $81,000
Q4 2023 Feb 08, 2024	SELL	$1.11 - $2.3 $147,475 - $305,580	-132,861 Reduced 73.66%	47,521 $81,000
Q3 2023 Nov 01, 2023	SELL	$1.76 - $3.04 $48,801 - $84,293	-27,728 Reduced 13.32%	180,382 $330,000
Q2 2023 Aug 02, 2023	SELL	$2.42 - $4.04 $79,545 - $132,794	-32,870 Reduced 13.64%	208,110 $616,000
Q1 2023 Jun 13, 2024	BUY	$2.77 - $5.49 $485,110 - $961,463	175,130 Added 325.49%	228,935 $634,000

Q4 2022 Feb 01, 2023	BUY	$4.5 - $5.72 $61,564 - $78,255	13,681 Added 6.02%	240,980 $1.26 Million
Q3 2022 Nov 10, 2022	BUY	$3.77 - $6.39 $124,918 - $211,732	33,135 Added 17.07%	227,299 $907,000
Q2 2022 Aug 11, 2022	BUY	$3.8 - $6.08 $204,098 - $326,556	53,710 Added 38.24%	194,164 $801,000
Q1 2022 May 12, 2022	BUY	$3.64 - $6.49 $197,087 - $351,401	54,145 Added 62.73%	140,454 $718,000
Q4 2021 Feb 11, 2022	BUY	$5.06 - $6.69 $202,450 - $267,666	40,010 Added 86.42%	86,309 $486,000
Q3 2021 Nov 12, 2021	BUY	$5.14 - $13.22 $5,525 - $14,211	1,075 Added 2.38%	46,299 $309,000
Q2 2021 Aug 12, 2021	BUY	$6.02 - $12.91 $272,248 - $583,841	45,224 New	45,224 $285,000

Others Institutions Holding IPA

# of Institutions

Shares Held

1.67M

Call Options Held

27.3K

Put Options Held

23.2K

View Full List

About ImmunoPrecise Antibodies Ltd.

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $25.1M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

More about IPA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account